Office of Dietary Supplements Carnitine. NIH Office of Dietary Supplements, U.S
Chemical class Small-molecule quinolinium compound Peptide status Not a peptide Primary research target Nicotinamide N-methyltransferase Common abbreviation 5A1MQ or 5-AMQ Evidence level Cell and animal research Human trials No controlled human trial identified UK approval No marketing authorisation identified Main evidence warning Mouse outcomes do not establish human results What Is 5-Amino-1MQ
It really depends on your lifestyle, diet, and how active you are
Our focus is on empowering you with the knowledge, skills, and resources necessary for lasting weight loss
no serious adverse events, no dose-limiting toxicities detected
NICE does not currently have guidance on either AOD 9604 or retatrutide, reflecting their unlicensed and investigational status within the UK healthcare system